Trials / Recruiting
RecruitingNCT06021288
Standard Dose Continuous Renal Replacement Therapy (CRRT) Versus Low-Dose CRRT ( KETZEREI )
A Randomized Controlled Study Investigating Standard Dose Continuous Renal Replacement Therapy (CRRT) Versus Low-Dose CRRT - The "Ketzerei" Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 165 (estimated)
- Sponsor
- Universität Münster · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Acute kidney injury (AKI) is a well-recognized complication in critically ill patients, which often leads to the necessity of mechanical kidney support (CRRT). In current therapeutic regimes, CRRT is used to strictly prevent azotaemia. Thus recent clinical observations, as well as data from animal testing suggest a link between controlled azotaemia and faster renal recovery in AKI patients. The aim of the study is to improve renal recovery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Effluent dose of CRRT | The effluent dose of the CRRT will be performed according to study group for 7 days or up to the end of CRRT, whatever occurs first. |
Timeline
- Start date
- 2023-10-02
- Primary completion
- 2025-04-30
- Completion
- 2025-06-30
- First posted
- 2023-09-01
- Last updated
- 2024-11-27
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT06021288. Inclusion in this directory is not an endorsement.